Breast Tomosynthesis The Use of Breast Tomosynthesis in a Clinical Setting

Since the United States (U.S.) Food and Drug Administration’s (FDA) approval of the first commercial systems in 2000, digital mammography has become an accepted standard of care in breast cancer screening and diagnosis and has paved the way for the newest groundbreaking technology in this arena – breast tomosynthesis, also referred to as tomosynthesis, or simply “tomo.”